Administration of Aza and Ctd in both fibroblasts and in PCLS of IPF patients rescued BAG3‐dependent autophagy and decreased fibroblast proliferation alongside with a significant decrease in the fibrosis marker COL1A1 in PCLS from IPF patients (Figure 7). This evidence concerns the gene COL1A1 and idiopathic interstitial pneumonia.